BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14748847)

  • 1. Good clinical practice is now obligatory in academic clinical drug research in the European Union.
    Jørgensen A; Bach KF; Friis K
    Basic Clin Pharmacol Toxicol; 2004 Feb; 94(2):57-8. PubMed ID: 14748847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Public GCP unit--experiences from the Aarhus University Hospital].
    Jørgensen A; Rønnow IL; Nexø E
    Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to establish GCP-units in Denmark?].
    Krogsgaard K; Andreasen PB
    Ugeskr Laeger; 2003 Apr; 165(16):1665-7. PubMed ID: 12756825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good clinical practice: a nuisance, a help or a necessity for clinical pharmacology?
    Sweatman J
    Br J Clin Pharmacol; 2003 Jan; 55(1):1-5. PubMed ID: 12534634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials].
    Dreier G; Marx C; Schmoor C; Maier-Lenz H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):445-52. PubMed ID: 15830256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of the GCP guidelines in Europe.
    Geussenhainer S
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?
    Knaapen M; Ploem MC; Kruijt M; Oudijk MA; van der Graaf R; Bet PM; Bakx R; van Heurn LWE; Gorter RR; van der Lee JH
    Eur J Pediatr; 2020 Aug; 179(8):1205-1211. PubMed ID: 32535715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological characteristics of academic clinical drug trials--a retrospective cohort study of applications to the Danish Medicines Agency 1993-2005.
    Berendt L; Håkansson C; Bach KF; Andreasen PB; Petersen LG; Andersen E; Poulsen HE; Dalhoff K
    Br J Clin Pharmacol; 2010 Nov; 70(5):729-35. PubMed ID: 21039767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell transplantation in children: how to design a new study.
    Corbacioglu S;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S30-4. PubMed ID: 18545241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GCP inspections of clinical trials].
    Schwarz G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):181-8. PubMed ID: 15726459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint.
    Legler UF
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of European Clinical Trials Directive on academic drug trials in Denmark: retrospective study of applications to the Danish Medicines Agency 1993-2006.
    Berendt L; Håkansson C; Bach KF; Dalhoff K; Andreasen PB; Petersen LG; Andersen E; Poulsen HE
    BMJ; 2008 Jan; 336(7634):33-5. PubMed ID: 18063611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reporting adverse reactions and events in randomised clinical trials].
    Hemmingsen B; Støy L; Wetterslev J; Tarnow L; Friis KB; Christensen LL; Sales N; Gluud C;
    Ugeskr Laeger; 2010 Aug; 172(35):2381-4. PubMed ID: 20825743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic investigator-initiated trials and the challenge of sponsor responsibility: the Cologne Sponsor Model.
    Georgias C; Grunow A; Olderog M; May A; Paulus U
    Clin Trials; 2012 Dec; 9(6):781-7. PubMed ID: 23104975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Good clinical practice (GCP)].
    Hvidberg E; Dirach J
    Theriaca; 1998 Sep; 31():7-53. PubMed ID: 11625363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [European guideline for the quality of non-commercial clinical trials: elegant implementation in the Netherlands via the amended Dutch Medical Research Involving Human Subjects Act].
    Cohen AF
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1493-5. PubMed ID: 12924078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.